About this trial
This is a single-center, randomized controlled trial evaluating the effectiveness of topical tetrachlorodecaoxide (TCDO) solution in enhancing chronic wound healing. The study will compare standard wound care with and without the addition of topical TCDO drops. Eligible adult participants with chronic wounds of more than six weeks' duration will be randomly assigned to either the intervention or control group. The trial aims to assess the rate of wound healing, time to 50% wound closure, pain reduction measured by the Visual Analog Scale (VAS), and cost-effectiveness.
Eligibility criteria
Qualifiers
Adults > 18 years diagnosed with chronic wounds (duration > 6 weeks)
Wound size between 5 and 10 cm²
Ankle-Brachial Pressure Index (ABPI) > 0.8 for venous leg ulcers
Palpable pulses for diabetic foot ulcers
Disqualifiers
Patients receiving immunosuppressive therapy or corticosteroids
Presence of malignancy
Patients who do not provide informed consent
Trial design
Treatments tested in this trial
- Topical Tetrachlorodecaoxide (TCDO/Oxoferin)
- Standard Wound Care
Treatment groups
Sponsors and collaborators
Fazeelat Bibi
Lead sponsor
Khyber Teaching Hospital
Sponsor institution